Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_14131 | 54 | 1.12 | Mlig455_039105 | Neo: - |
Mlig455_039105 {REF} {Length: 3876} {RNA1310_38427} {RNA815_24357} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.777 | 1.304 | 1.00000 | 1.00000 | |
RegionR2 | 1.3 | 1.304 | 0.35827 | 0.75289 | |
RegionR3 | 0.837 | 1.304 | 0.48115 | 0.98308 | |
RegionR4 | 0.124 | 1.304 | 0.75068 | 1.00000 | |
RegionR5 | 0.219 | 1.304 | 0.71622 | 1.00000 | |
RegionR6 | 0.588 | 1.304 | 0.59266 | 1.00000 | |
RegionR7 | 3.06 | 1.304 | 0.01369 | 0.20825 | |
RegionR8 | -3.352 | 1.304 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -1.177 | 1.304 | 0.99996 | 1.00000 | |
RegenerationR2 | -5.132 | 1.304 | 0.00012 | 0.01334 | |
RegenerationR3 | -1.1 | 1.304 | 0.27996 | 0.71281 | |
RegenerationR4 | -1.563 | 1.304 | 0.16358 | 0.59734 | |
RegenerationR5 | -1.676 | 1.304 | 0.09882 | 0.47976 | |
RegenerationR6 | -1.071 | 1.304 | 0.31953 | 0.66635 | |
RegenerationBL | -0.467 | 1.304 | 0.88947 | 1.00000 | |
RegenerationTP | 0.42 | 1.304 | 0.73367 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_14131 | 54 | 1.12 | Mlig455_039105 | Neo: - |
4 | 1.000 | - | 1.000 | - | 1.000 | 1.000 | Mlig455_039105 {REF} {Length: 3876} {RNA1310_38427} {RNA815_24357} | |
2. | MligTC455_11926 | 101 | 2.11 | Mlig455_021319 | Neo: - Age: - Region-enriched R7: 4.905/0.00107 |
1.709 | - | - | 0.748 | - | - | 0.961 | Mlig455_021319 {REF} {Length: 2758} {Pfam: Mab-21 protein [PF03281.16, score=23.9]} {RNA1509_41055} {RNA1310_11481.1} {RNA815_44675} | |
3. | MligTC455_32436 | 43 | 0.91 | Mlig455_025074 | Neo: - Age: - |
1.674 | - | - | 0.705 | - | - | 0.969 | Mlig455_025074 {REF} {Length: 2851} {RNA1509_1845} {RNA1310_50.1} {RNA815_5933} | |
4. | MligTC455_28655 | 49 | 1.03 | Mlig455_048319 | Neo: - |
RNF213 | 0.982 | - | - | - | - | - | 0.982 | Mlig455_048319 {REF} {Length: 12875} {Pfam: ATPase family associated with various cellular activities (AAA) [PF00004.31, score=25.3]; AAA domain (dynein-related subfamily) [PF07728.16, score=23.1]} {Human: ENSG00000173821, RNF213, ring finger protein 213, [Score=329, Expect=5e-89]} {Mouse: ENSMUSG00000070327, Rnf213, ring finger protein 213, [Score=319, Expect=3e-86]} {RNA1509_30363} {RNA1310_550} {RNA815_15} |
5. | MligTC455_42108 | 83 | 1.73 | Mlig455_063983 | Neo: - Age: Up-Down-Down |
COL6A6 | 0.978 | - | - | - | - | - | 0.978 | Mlig455_063983 {REF} {Length: 6296} {Pfam: von Willebrand factor type A domain [PF00092.30, score=243.5]; von Willebrand factor type A domain [PF13519.8, score=104.9]} {Human: ENSG00000206384, COL6A6, collagen type VI alpha 6 chain, [Score=88.6, Expect=1e-16]; ENSG00000111799, COL12A1, collagen type XII alpha 1 chain, [Score=85.5, Expect=1e-15]} {Mouse: ENSMUSG00000032332, Col12a1, collagen, type XII, alpha 1, [Score=85.1, Expect=1e-15]; ENSMUSG00000025650, Col7a1, collagen, type VII, alpha 1, [Score=84.7, Expect=1e-15]; ENSMUSG00000022371, Col14a1, collagen, type XIV, alpha 1, [Score=83.6, Expect=3e-15]; ENSMUSG00000022324, Matn2, matrilin 2, [Score=80.9, Expect=1e-14]} {Celegans: WBGene00019570, K09E2.1, [RH, Score=60.8, Expect=1e-08]} {Smed: dd_Smed_v6_1071_0_1, dd_Smed_v6_1071_0_1, [RH, Score=142, Expect=4e-34]} {RNA1509_1372} {RNA1310_280.1} {RNA815_108} |
6. | MligTC455_34093 | 75 | 1.56 | Mlig455_060808 | Neo: - Age: logFC(26M/2M)=-0.412 |
0.976 | - | - | - | - | 0.976 | - | Mlig455_060808 {REF} {Length: 3019} {RNA1509_35315} {RNA1310_28904.1} {RNA815_22847.1} | |
7. | MligTC455_21582 | 28 | 0.58 | Mlig455_048795 | Neo: - Age: - |
0.967 | - | - | - | - | - | 0.967 | Mlig455_048795 {REF} {Length: 582} {NoTransDecoderORF} | |
8. | MligTC455_55083 | 36 | 0.74 | Mlig455_027752 | Neo: - Age: - |
0.965 | - | - | - | - | - | 0.965 | Mlig455_027752 {REF} {Length: 185} {NoTransDecoderORF} {RNA1509_37847} {RNA1310_25173} | |
9. | MligTC455_09045 | 28 | 0.58 | Mlig455_030695 | Neo: - Age: - Region-enriched R3: 3.801/0.03726 |
0.963 | - | - | - | - | - | 0.963 | Mlig455_030695 {REF} {Length: 163} {NoTransDecoderORF} | |
10. | MligTC455_34192 | 134 | 2.8 | Mlig455_022589 | Neo: - Age: - |
0.963 | - | - | - | - | - | 0.963 | Mlig455_022589 {REF} {Length: 1896} {RNA1509_34101} {RNA1310_46799} {RNA815_22648} | |
11. | MligTC455_09301 | 26 | 0.55 | Mlig455_011440 | Neo: - Age: - Regeneration-upregulated BL: 7.313 Regeneration-enriched BL: 7.313 |
0.961 | - | - | - | - | - | 0.961 | Mlig455_011440 {REF} {Length: 331} {NoTransDecoderORF} {RNA1509_58496} {RNA1310_68696} {RNA815_38510} | |
12. | MligTC455_21390 | 470 | 9.8 | Mlig455_013297, Mlig455_050507 | Neo: - Age: - |
0.961 | - | - | - | - | - | 0.961 | Mlig455_013297 {REF} {Length: 1363} {TRANSSPLICED} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=51.6]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=129, Expect=2e-34]} {RNA1509_33360} {RNA1310_24109.1} {RNA815_9543} Mlig455_050507 {REF} {Length: 1891} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=51.6]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=129, Expect=1e-34]} {RNA1509_33360} {RNA1310_24109.3} {RNA815_9543} |
|
13. | MligTC455_26645 | 132 | 2.74 | Mlig455_032393, Mlig455_032437 | Neo: - Age: - |
B4GALT1 | 0.96 | - | - | - | - | - | 0.960 | Mlig455_032393 {REF} {Length: 2140} {Pfam: N-terminal region of glycosyl transferase group 7 [PF13733.8, score=128.2]; N-terminal domain of galactosyltransferase [PF02709.16, score=66.3]} {Human: ENSG00000086062, B4GALT1, beta-1,4-galactosyltransferase 1, [Score=178, Expect=1e-51]} {Mouse: ENSMUSG00000028413, B4galt1, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1, [Score=174, Expect=4e-50]} {Dmel: FBgn0027538, beta4GalNAcTA, [Score=149, Expect=6e-41]} {Celegans: WBGene00000269, bre-4, Beta-1,4-N-acetylgalactosaminyltransferase bre-4, [Score=166, Expect=2e-47]} {Smed: dd_Smed_v6_12436_0_1, dd_Smed_v6_12436_0_1, [Score=174, Expect=7e-51]} {RNA1310_17913} {RNA815_20156} Mlig455_032437 {REF} {Length: 2249} {Pfam: N-terminal region of glycosyl transferase group 7 [PF13733.8, score=126.3]; N-terminal domain of galactosyltransferase [PF02709.16, score=66.3]} {Human: ENSG00000086062, B4GALT1, beta-1,4-galactosyltransferase 1, [Score=181, Expect=9e-53]} {Mouse: ENSMUSG00000028413, B4galt1, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1, [Score=176, Expect=5e-51]} {Dmel: FBgn0027538, beta4GalNAcTA, [Score=149, Expect=6e-41]} {Celegans: WBGene00000269, bre-4, Beta-1,4-N-acetylgalactosaminyltransferase bre-4, [Score=166, Expect=2e-47]} {Smed: dd_Smed_v6_12436_0_1, dd_Smed_v6_12436_0_1, [Score=172, Expect=3e-50]} {RNA1310_17913} {RNA815_20156} |
14. | MligTC455_41818 | 52 | 1.08 | Mlig455_067797 | Neo: - Age: Down-Up-Up |
0.959 | - | - | 0.959 | - | - | - | Mlig455_067797 {REF} {Length: 2072} {TRANSSPLICED} {RNA1509_26844} {RNA1310_16013.2} {RNA815_32730} | |
15. | MligTC455_52665 | 33 | 0.68 | Mlig455_040206 | Neo: - Age: Down-Up-Down |
0.955 | - | - | - | - | - | 0.955 | Mlig455_040206 {REF} {Length: 2666} {Pfam: Family of unknown function (DUF5731) [PF19002.2, score=141.4]} {RNA1509_54737} {RNA1310_23581.1, RNA1509_54737} {RNA1509_54737, RNA815_50984} | |
16. | MligTC455_53118 | 133 | 2.76 | Mlig455_029477 | Neo: - Age: - |
CHRNA2 | 0.955 | - | - | - | - | - | 0.955 | Mlig455_029477 {REF} {Length: 3006} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=160.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.2]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=212, Expect=1e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=210, Expect=4e-59]} {Mouse: ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=209, Expect=3e-59]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=207, Expect=2e-59]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=204, Expect=1e-58]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=204, Expect=4e-58]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=208, Expect=1e-57]} {Celegans: WBGene00043066, acr-25, AcetylCholine Receptor, [Score=202, Expect=2e-57]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=437, Expect=6e-147]} {RNA1509_18288} {RNA1310_21192} {RNA815_24334} |
17. | MligTC455_48225 | 63 | 1.31 | Mlig455_056723, Mlig455_060295 | Neo: - Age: - |
GLRA3 | 0.954 | - | - | - | - | - | 0.954 | Mlig455_056723 {REF} {Length: 2758} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=152.2]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=129.4]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=270, Expect=2e-84]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=265, Expect=1e-82]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=264, Expect=3e-82]; ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=258, Expect=3e-80]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=265, Expect=7e-83]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=263, Expect=4e-82]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=263, Expect=6e-82]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=257, Expect=1e-79]; ENSMUSG00000033676, Gabrb3, gamma-aminobutyric acid (GABA) A receptor, subunit beta 3, [Score=255, Expect=9e-79]; ENSMUSG00000029212, Gabrb1, gamma-aminobutyric acid (GABA) A receptor, subunit beta 1, [Score=253, Expect=9e-78]} {Dmel: FBgn0024963, GluClalpha, [Score=254, Expect=1e-78]} {Celegans: WBGene00001593, glc-3, Glutamate-gated ChLoride channel; Glutamate-gated chloride channel subunit, [RH, Score=255, Expect=4e-79]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=224, Expect=4e-67]} {RNA1310_13574.1} {RNA815_10577.1} Mlig455_060295 {REF} {Length: 2660} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=129.6]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=95.7]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=240, Expect=4e-73]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=235, Expect=3e-71]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=233, Expect=8e-71]} {Mouse: ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=234, Expect=4e-71]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=233, Expect=2e-70]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=233, Expect=5e-71]; ENSMUSG00000033676, Gabrb3, gamma-aminobutyric acid (GABA) A receptor, subunit beta 3, [Score=226, Expect=7e-68]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=225, Expect=7e-68]} {Dmel: FBgn0024963, GluClalpha, [Score=215, Expect=4e-64]} {Celegans: WBGene00001593, glc-3, Glutamate-gated ChLoride channel; Glutamate-gated chloride channel subunit, [Score=222, Expect=2e-66]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=188, Expect=4e-54]} {RNA1310_13574.1} {RNA815_10577.1} |
18. | MligTC455_47765 | 12 | 0.25 | Mlig455_068551 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_068551 {REF} {Length: 4208} {RNA1509_51612} {RNA1310_8696} {RNA815_20831} | |
19. | MligTC455_51339 | 75 | 1.56 | Mlig455_024282 | Neo: - Age: - |
0.953 | - | - | 0.953 | - | - | - | Mlig455_024282 {REF} {Length: 2404} {RNA1310_48051} {RNA815_14784} | |
20. | MligTC455_28130 | 73 | 1.52 | Mlig455_017884 | Neo: - Age: - |
0.952 | - | - | - | - | - | 0.952 | Mlig455_017884 {REF} {Length: 3157} {NoTransDecoderORF} {RNA1509_13222} {RNA1310_34828.2} {RNA815_11419.1} | |
21. | MligTC455_40922 | 2760 | 57.5 | Mlig455_019713 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.414 Region-enriched R7: 1.766/0.00003 |
0.952 | - | - | - | - | - | 0.952 | Mlig455_019713 {REF} {Length: 2146} {Pfam: Zinc-binding domain [PF13695.8, score=81.1]} {Mouse: ENSMUSG00000033355, Rtp4, receptor transporter protein 4, [RH, Score=62.8, Expect=7e-11]} {Smed: dd_Smed_v6_4477_0_1, dd_Smed_v6_4477_0_1, [Score=101, Expect=4e-25]} {RNA1509_3607, RNA1509_45450, RNA1509_51216} {RNA1310_14449, RNA1509_3607, RNA1509_45450, RNA1509_51216} {RNA1509_3607, RNA1509_45450, RNA1509_51216, RNA815_2235} | |
22. | MligTC455_52313 | 53 | 1.1 | Mlig455_036461 | Neo: - Age: - |
0.952 | - | - | - | - | - | 0.952 | Mlig455_036461 {REF} {Length: 242} {NoTransDecoderORF} {RNA1509_5075} | |
23. | MligTC455_14677 | 21 | 0.44 | Mlig455_004558, Mlig455_064752 | Neo: - Age: - |
TRPM2 | 0.95 | - | - | - | - | - | 0.950 | Mlig455_004558 {REF} {Length: 1754} {Pfam: SLOG in TRPM [PF18139.3, score=98.9]; Ankyrin repeats (3 copies) [PF12796.9, score=36.5]; Ankyrin repeat [PF13606.8, score=23.8]; Ankyrin repeat [PF00023.32, score=22.8]; Ankyrin repeats (many copies) [PF13857.8, score=20.3]; Ankyrin repeats (many copies) [PF13637.8, score=20.1]} {Human: ENSG00000142185, TRPM2, transient receptor potential cation channel subfamily M member 2, [Score=134, Expect=1e-32]} {Mouse: ENSMUSG00000009292, Trpm2, transient receptor potential cation channel, subfamily M, member 2, [Score=126, Expect=4e-30]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=82.0, Expect=5e-16]} {Celegans: WBGene00001651, gon-2, Transient receptor potential channel, [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_17981_0_3, dd_Smed_v6_17981_0_3, [Score=157, Expect=3e-41]} {RNA1310_103417} Mlig455_064752 {REF} {Length: 2527} {Pfam: SLOG in TRPM [PF18139.3, score=98.9]; Ankyrin repeats (3 copies) [PF12796.9, score=37.5]; Ankyrin repeat [PF13606.8, score=26.1]; Ankyrin repeats (many copies) [PF13637.8, score=25.3]; Ankyrin repeats (many copies) [PF13857.8, score=24.8]; Ankyrin repeat [PF00023.32, score=23.9]} {Human: ENSG00000142185, TRPM2, transient receptor potential cation channel subfamily M member 2, [Score=135, Expect=5e-33]} {Mouse: ENSMUSG00000009292, Trpm2, transient receptor potential cation channel, subfamily M, member 2, [Score=128, Expect=1e-30]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=82.4, Expect=5e-16]} {Celegans: WBGene00001651, gon-2, Transient receptor potential channel, [Score=96.3, Expect=2e-20]} {Smed: dd_Smed_v6_17981_0_3, dd_Smed_v6_17981_0_3, [Score=157, Expect=4e-41]} {RNA1509_36146} {RNA1310_103417} {RNA815_131.5} |
24. | MligTC455_31046 | 12 | 0.25 | Mlig455_054928 | Neo: - Age: - |
LRRN3 | 0.95 | - | - | - | - | 0.950 | - | Mlig455_054928 {REF} {Length: 3787} {Pfam: Immunoglobulin domain [PF13927.8, score=35.6]; Immunoglobulin I-set domain [PF07679.18, score=34.7]; Immunoglobulin domain [PF00047.27, score=29.3]; Apolipoprotein A1/A4/E domain [PF01442.20, score=20.1]} {Human: ENSG00000173114, LRRN3, leucine rich repeat neuronal 3, [Score=53.5, Expect=1e-06]} {Dmel: FBgn0032479, CG16974, [RH, Score=114, Expect=1e-25]} {RNA1509_10344} {RNA1310_3046.1} {RNA815_12103} |
25. | MligTC455_47787 | 741 | 15.44 | Mlig455_059451 | Neo: - Age: logFC(26M/2M)=-0.505 Region-enriched R8: 1.658/0.04622 |
0.95 | - | - | - | - | - | 0.950 | Mlig455_059451 {REF} {Length: 2112} {RNA1509_40006} {RNA1310_14082, RNA1509_40006} {RNA1509_40006, RNA815_12176} |